Key result
Planned PREOP-ECHO trial will evaluate if preoperative TTE reduces postoperative cardiovascular events in noncardiac surgery.
Why the study?
Evidence supporting the use of preoperative transthoracic echocardiography to predict postoperative cardiovascular events in intermediate- and high-risk noncardiac surgery patients is lacking.
Does preoperative transthoracic echocardiography reduce postoperative cardiovascular events in patients undergoing intermediate- to high-risk noncardiac surgery?
Does preoperative transthoracic echocardiography reduce postoperative cardiovascular events in patients undergoing intermediate- to high-risk noncardiac surgery?
This study protocol outlines a large-scale trial to determine if routine preoperative echocardiography reduces 30-day postoperative cardiovascular events in asymptomatic patients undergoing intermediate- to high-risk noncardiac surgery.
Answers are grounded in this paper and cite their sources.
Preoperative echocardiography should not yet be routine before noncardiac surgery; the planned PREOP-ECHO trial will test its effect on events.
BACKGROUND: Cardiac evaluation using transthoracic echocardiography before noncardiac surgery is common in real-world practice. However, evidence supporting preoperative echocardiography is lacking. This study aims to evaluate the additional benefit of preoperative echocardiography in predicting postoperative cardiovascular events (CVE) in noncardiac surgery. METHODS: This study is designed as a multicenter, prospective study to assess the utility of preoperative echocardiography in patients undergoing intermediate- or high-risk noncardiac surgery. This trial comprises two studies: (1) a randomized controlled trial (RCT) for patients undergoing intermediate-risk surgery with fewer than three clinical risk factors from the revised cardiac risk index (intermediate-risk group) and (2) a prospective cohort study for patients undergoing intermediate-risk surgery with three or more clinical risk factors, or who undergo high-risk surgery regardless of the number of clinical risk factors (high-risk group). We hypothesize that the use of preoperative echocardiography will reduce postoperative CVEs in patients undergoing intermediate- to high-risk surgery through discovery of and further intervention for unexpected cardiac abnormalities before elective surgery. A total of 2330 and 2184 patients will be enrolled in the two studies. The primary endpoint is a composite of all-cause death; aborted sudden cardiac arrest; type I acute myocardial infarction; clinically diagnosed unstable angina; stress-induced cardiomyopathy; lethal arrhythmia, such as sustained ventricular tachycardia or ventricular fibrillation; and/or newly diagnosed or acutely decompensated heart failure within 30 days after surgery. DISCUSSION: This study will be the first large-scale prospective study examining the benefit of preoperative echocardiography in predicting postoperative CVE. The PREOP-ECHO trial will help doctors identify patients at risk of postoperative CVE using echocardiography and thereby reduce postoperative CVEs. TRIAL REGISTRATION: The Clinical Research Information Service KCT0006279 for RCT and KCT0006280 for prospective cohort study. Registered on June 21, 2021.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2022) studied Intermediate- or high-risk noncardiac surgery (n=4,514). Preoperative transthoracic echocardiography vs. No preoperative echocardiography was evaluated on Composite of all-cause death, aborted sudden cardiac arrest, type I acute myocardial infarction, clinically diagnosed unstable angina, stress-induced cardiomyopathy, lethal arrhythmia, and newly diagnosed or acutely decompensated heart failure within 30 days after surgery. The PREOP-ECHO trial is a planned multicenter study designed to evaluate whether preoperative echocardiography reduces postoperative cardiovascular events in 4,514 patients undergoing noncardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: